This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.
Approval for the c2a-taper acetabular system. The device is indicated for use in primary total hip arthroplasty in skeletally mature patients with non-inflammatory degenerative joint disease such as osteoarthritis, avascular necrosis, congenital hip dysplasia, and post-traumatic arthritis.
| Device | C2 A-TAPER ACETABULAR SYSTEM |
| Generic Name | Prosthesis, Hip, Semi-constrained, Metal/ceramic/ceramic/metal, Cemented Or Uncemented |
| Applicant | Biomet, Inc. |
| Date Received | 2005-03-14 |
| Decision Date | 2005-12-16 |
| Notice Date | 2006-01-13 |
| PMA | P050009 |
| Supplement | S |
| Product Code | MRA |
| Docket Number | 06M-0015 |
| Advisory Committee | Orthopedic |
| Expedited Review | No |
| Combination Product | No |
| Applicant Address | Biomet, Inc. p.o. Box 587 warsaw, IN 46581-0587 |
| Summary: | Summary of Safety and Effectiveness |
| Labeling: | Labeling Labeling Part 2 |
| Post-Approval Study: | Show Report Schedule and Study Progress |
| Approval Order: | Approval Order |
| Supplement Number | Date | Supplement Type |
|---|---|---|
| P050009 | Original Filing | |
| S009 | 2010-02-16 | Normal 180 Day Track No User Fee |
| S008 | ||
| S007 | 2009-02-19 | 30-day Notice |
| S006 | ||
| S005 | 2007-11-02 | 30-day Notice |
| S004 | 2007-09-27 | 135 Review Track For 30-day Notice |
| S003 | ||
| S002 | 2006-05-19 | 30-day Notice |
| S001 | 2006-01-10 | 30-day Notice |